INNOSCRIPTA SE INH O.N. Logo
DE000A40QVM8
A40QVM

INNOSCRIPTA SE INH O.N.

Prognose

Vi har ingen analytikerdata for denne virksomhed.

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Innoscripta after searches over suspected tax offenses: stock plunges 57%

    Innoscripta reported searches in connection with a criminal tax investigation into suspected assistance in obtaining unjustified tax advantages for research allowances by customers. The share then fell by 57% and continued to lose value, while the company says it is examining possible misconduct by individual employees. Analysts such as Warburg Research suspended ratings and price targets and warn of risks including refunds, customer losses, liability claims or fines; the financial consequences remain unclear. » Mere på deraktionaer.de


  • Searches at innoscripta over investigations into research allowances

    Business premises of innoscripta were searched following two orders from the Amtsgericht Schwäbisch Gmünd in a tax-criminal proceeding on suspicion of aiding the procurement of unauthorized research allowances. According to the search warrants, the investigations concern possible misconduct by individual employees in handling certain client mandates. The company is conducting a thorough review of the matters, is cooperating with the authorities and emphasizes that decisions on applications and responsibility for information lie with the clients. Any effects on the innoscripta group cannot yet be conclusively assessed. » Mere på finanzen.net


  • Innoscripta reports strong growth, international expansion and higher earnings

    Innoscripta reports a 43% revenue increase and a 49% rise in EBIT in the first half, driven by strong new customer acquisition; the customer base grew to over 2,900. The company is expanding with new offices in the UK, France and the US and expects significant foreign revenues from 2027. Management emphasizes the use of AI to boost efficiency, employee share participation as a retention tool, and aims to develop a global R&D software platform over the long term, while the share price lags behind operational progress. » Mere på deraktionaer.de


  • innoscripta: manager buys 10,000 shares at EUR 81.25

    On 31.08.2026 Hohenester Beteiligungs-UG acquired 10,000 innoscripta shares at a price of EUR 81.25. Previously, the same party had on 26.08.2026 already bought 10,000 units at EUR 73.90 each. Market capitalization is about EUR 801 million, and the free float comprises around 10,000,000 shares. In trading the stock showed short-term fluctuations and last traded at around EUR 81.90. » Mere på finanzen.net


  • Innoscripta share falls after Q2 update due to software migration

    Innoscripta reported H1 2026 revenue growth of 43% to EUR 63m and an EBIT increase of 49% to EUR 36.4m, but confirmed its full-year guidance of EUR 140m revenue and EUR 80m EBIT. The stock fell about 9% after it said a software migration delayed filings and shifted parts of revenue into later quarters. Management expects the deferred volume to be recovered in H2 and is advancing expansion in France, the USA and the UK, but does not expect any material revenues there in 2026. The stock now trades at a P/E of 20.3 and a market capitalization of USD 961m. » Mere på de.investing.com

I 2026 har INNOSCRIPTA SE INH O.N. allerede udloddet 4,00 € i udbytte. Den seneste udlodning fandt sted i april.

🍪

Parqet  bruger cookies. Læs mere